Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: a meta-analysis

about

Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: a meta-analysis

Item

http://www.wikidata.org/entity/Q58791399

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Irinotecan-platinum combinatio ...... ncer patients: a meta-analysis

@en

Irinotecan-platinum combinatio ...... ncer patients: a meta-analysis

@nl

type

Item

label

Irinotecan-platinum combinatio ...... ncer patients: a meta-analysis

@en

Irinotecan-platinum combinatio ...... ncer patients: a meta-analysis

@nl

prefLabel

Irinotecan-platinum combinatio ...... ncer patients: a meta-analysis

@en

Irinotecan-platinum combinatio ...... ncer patients: a meta-analysis

@nl

P1476

Irinotecan-platinum combinatio ...... ncer patients: a meta-analysis

@en

P2093

Fei Xu

http://www.w3.org/2001/XMLSchema#string

Qianxia Li

http://www.w3.org/2001/XMLSchema#string

Ruichao Li

http://www.w3.org/2001/XMLSchema#string

Shu Xia

http://www.w3.org/2001/XMLSchema#string

Xiaoli Ren

http://www.w3.org/2001/XMLSchema#string

Yu Chen

http://www.w3.org/2001/XMLSchema#string

Yuan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Small cell lung cancer (SCLC): no treatment advances in recent years

Practical methods for incorporating summary time-to-event data into meta-analysis

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.

Safety of irinotecan/cisplatin versus etoposide/cisplatin for patients with extensive-stage small-cell lung cancer: a metaanalysis.

Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.

A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer.

Irinotecan plus cisplatin compared with etoposide plus cisplatin for small cell lung cancer: a randomized clinical trial.

Cisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial.

Basic treatment considerations using chemotherapy for patients with small cell lung cancer.

Treatment of extensive small cell lung cancer.

P2888

s12885-018-4715-9

P304

808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1186/S12885-018-4715-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106106855

http://www.w3.org/2001/XMLSchema#string

P698

30097029

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6086076

http://www.w3.org/2001/XMLSchema#string